Listed

Atossa Therapeutics, Inc.

ATOSNasdaqCIK 1488039HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Operating income−$8.7m, Q2 FY2026
Net income−$8.5m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Cost of revenue$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Gross profit$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Research and development$m4.5Research and development, Q3 FY2023, three months to 2023-09-30$4.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-12, accession 0000950170-24-124668.Report this figure5.7Research and development, Q4 FY2023, three months to 2023-12-31$5.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-25, accession 0000950170-25-044099. Derived: 12-month figure less the 9-month figure.Report this figure3.7Research and development, Q1 FY2024, three months to 2024-03-31$3.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-13, accession 0000950170-25-069827.Report this figure3.6Research and development, Q2 FY2024, three months to 2024-06-30$3.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-12, accession 0000950170-25-106947.Report this figure3.4Research and development, Q3 FY2024, three months to 2024-09-30$3.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001193125-25-276160.Report this figure3.4Research and development, Q4 FY2024, three months to 2024-12-31$3.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-25, accession 0001193125-26-124396. Derived: 12-month figure less the 9-month figure.Report this figure4.2Research and development, Q1 FY2025, three months to 2025-03-31$4.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-08, accession 0001193125-26-213423.Report this figure5.5Research and development, Q2 FY2025, three months to 2025-06-30$5.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-07, accession 0001193125-26-339257.Report this figure5.4Research and development, Q3 FY2025, three months to 2025-09-30$5.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001193125-25-276160.Report this figure6.2Research and development, Q4 FY2025, three months to 2025-12-31$6.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-25, accession 0001193125-26-124396. Derived: 12-month figure less the 9-month figure.Report this figure4.8Research and development, Q1 FY2026, three months to 2026-03-31$4.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-08, accession 0001193125-26-213423.Report this figure4.9Research and development, Q2 FY2026, three months to 2026-06-30$4.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-07, accession 0001193125-26-339257.Report this figure
Operating income$m(7.5)Operating income, Q3 FY2023, three months to 2023-09-30−$7.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-12, accession 0000950170-24-124668.Report this figure(9.0)Operating income, Q4 FY2023, three months to 2023-12-31−$9.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-25, accession 0000950170-25-044099. Derived: 12-month figure less the 9-month figure.Report this figure(7.0)Operating income, Q1 FY2024, three months to 2024-03-31−$7.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-13, accession 0000950170-25-069827.Report this figure(7.1)Operating income, Q2 FY2024, three months to 2024-06-30−$7.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-12, accession 0000950170-25-106947.Report this figure(6.4)Operating income, Q3 FY2024, three months to 2024-09-30−$6.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-276160.Report this figure(7.2)Operating income, Q4 FY2024, three months to 2024-12-31−$7.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-25, accession 0001193125-26-124396. Derived: 12-month figure less the 9-month figure.Report this figure(7.4)Operating income, Q1 FY2025, three months to 2025-03-31−$7.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-08, accession 0001193125-26-213423.Report this figure(9.0)Operating income, Q2 FY2025, three months to 2025-06-30−$9.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-07, accession 0001193125-26-339257.Report this figure(9.3)Operating income, Q3 FY2025, three months to 2025-09-30−$9.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-276160.Report this figure(11.4)Operating income, Q4 FY2025, three months to 2025-12-31−$11.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-25, accession 0001193125-26-124396. Derived: 12-month figure less the 9-month figure.Report this figure(9.9)Operating income, Q1 FY2026, three months to 2026-03-31−$9.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-08, accession 0001193125-26-213423.Report this figure(8.7)Operating income, Q2 FY2026, three months to 2026-06-30−$8.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-07, accession 0001193125-26-339257.Report this figure
Interest expense$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Income tax$m0.0Income tax, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-12, accession 0000950170-24-124668.Report this figure0.0Income tax, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-03-25, accession 0000950170-25-044099. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-13, accession 0000950170-25-069827.Report this figure0.0Income tax, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-12, accession 0000950170-25-106947.Report this figure0.0Income tax, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-12, accession 0001193125-25-276160.Report this figure0.0Income tax, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-25, accession 0001193125-26-124396. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-08, accession 0001193125-26-213423.Report this figure0.0Income tax, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-07, accession 0001193125-26-339257.Report this figure0.0Income tax, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-12, accession 0001193125-25-276160.Report this figure0.0Income tax, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-25, accession 0001193125-26-124396. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-08, accession 0001193125-26-213423.Report this figure0.0Income tax, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-07, accession 0001193125-26-339257.Report this figure
Net income$m(6.2)Net income, Q3 FY2023, three months to 2023-09-30−$6.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-12, accession 0000950170-24-124668.Report this figure(7.8)Net income, Q4 FY2023, three months to 2023-12-31−$7.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-25, accession 0000950170-25-044099. Derived: 12-month figure less the 9-month figure.Report this figure(5.9)Net income, Q1 FY2024, three months to 2024-03-31−$5.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-276160.Report this figure(6.0)Net income, Q2 FY2024, three months to 2024-06-30−$6.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-276160.Report this figure(7.2)Net income, Q3 FY2024, three months to 2024-09-30−$7.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-276160.Report this figure(6.3)Net income, Q4 FY2024, three months to 2024-12-31−$6.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-25, accession 0001193125-26-124396. Derived: 12-month figure less the 9-month figure.Report this figure(6.7)Net income, Q1 FY2025, three months to 2025-03-31−$6.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-07, accession 0001193125-26-339257.Report this figure(8.4)Net income, Q2 FY2025, three months to 2025-06-30−$8.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-07, accession 0001193125-26-339257.Report this figure(8.7)Net income, Q3 FY2025, three months to 2025-09-30−$8.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-276160.Report this figure(10.9)Net income, Q4 FY2025, three months to 2025-12-31−$10.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-25, accession 0001193125-26-124396. Derived: 12-month figure less the 9-month figure.Report this figure(9.6)Net income, Q1 FY2026, three months to 2026-03-31−$9.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-07, accession 0001193125-26-339257.Report this figure(8.5)Net income, Q2 FY2026, three months to 2026-06-30−$8.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-07, accession 0001193125-26-339257.Report this figure
Diluted EPS$ per share(0.05)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-12, accession 0000950170-24-124668.Report this figurenot reported(0.05)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-13, accession 0000950170-25-069827.Report this figure(0.05)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-12, accession 0000950170-25-106947.Report this figure(0.06)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.06 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001193125-25-276160.Report this figurenot reported(0.78)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.78 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-08, accession 0001193125-26-213423.Report this figure(0.98)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.98 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-07, accession 0001193125-26-339257.Report this figure(0.07)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.07 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001193125-25-276160.Report this figurenot reported(1.11)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$1.11 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-08, accession 0001193125-26-213423.Report this figure(0.95)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.95 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-07, accession 0001193125-26-339257.Report this figure
Basic EPS$ per share(0.05)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.05 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-12, accession 0000950170-24-124668.Report this figurenot reported(0.05)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.05 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-13, accession 0000950170-25-069827.Report this figure(0.05)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.05 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-12, accession 0000950170-25-106947.Report this figure(0.06)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.06 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001193125-25-276160.Report this figurenot reported(0.78)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.78 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-08, accession 0001193125-26-213423.Report this figure(0.98)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.98 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-07, accession 0001193125-26-339257.Report this figure(0.07)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.07 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001193125-25-276160.Report this figurenot reported(1.11)Basic EPS, Q1 FY2026, three months to 2026-03-31−$1.11 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-08, accession 0001193125-26-213423.Report this figure(0.95)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.95 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-07, accession 0001193125-26-339257.Report this figure

Balance sheet

Cash and equivalents$26.1m, Q2 FY2026
Shareholders' equity$26.8m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m94.0Cash and equivalents, Q3 FY2023, at 2023-09-30$94.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-12, accession 0000950170-24-124668.Report this figure88.5Cash and equivalents, FY2023, at 2023-12-31$88.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-25, accession 0000950170-25-044099.Report this figure84.0Cash and equivalents, Q1 FY2024, at 2024-03-31$84.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-13, accession 0000950170-25-069827.Report this figure79.5Cash and equivalents, Q2 FY2024, at 2024-06-30$79.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-12, accession 0000950170-25-106947.Report this figure74.8Cash and equivalents, Q3 FY2024, at 2024-09-30$74.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-12, accession 0001193125-25-276160.Report this figure71.1Cash and equivalents, FY2024, at 2024-12-31$71.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-25, accession 0001193125-26-124396.Report this figure65.1Cash and equivalents, Q1 FY2025, at 2025-03-31$65.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-08, accession 0001193125-26-213423.Report this figure57.9Cash and equivalents, Q2 FY2025, at 2025-06-30$57.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-07, accession 0001193125-26-339257.Report this figure51.8Cash and equivalents, Q3 FY2025, at 2025-09-30$51.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-12, accession 0001193125-25-276160.Report this figure41.3Cash and equivalents, FY2025, at 2025-12-31$41.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-07, accession 0001193125-26-339257.Report this figure31.7Cash and equivalents, Q1 FY2026, at 2026-03-31$31.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-08, accession 0001193125-26-213423.Report this figure26.1Cash and equivalents, Q2 FY2026, at 2026-06-30$26.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-07, accession 0001193125-26-339257.Report this figure
Current assets$m97.6Current assets, Q3 FY2023, at 2023-09-30$97.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-13, accession 0001437749-23-031424.Report this figure92.2Current assets, FY2023, at 2023-12-31$92.2m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-25, accession 0000950170-25-044099.Report this figure87.1Current assets, Q1 FY2024, at 2024-03-31$87.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-13, accession 0000950170-24-058244.Report this figure81.7Current assets, Q2 FY2024, at 2024-06-30$81.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-12, accession 0000950170-24-095102.Report this figure77.1Current assets, Q3 FY2024, at 2024-09-30$77.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-12, accession 0000950170-24-124668.Report this figure74.5Current assets, FY2024, at 2024-12-31$74.5m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-25, accession 0001193125-26-124396.Report this figure68.7Current assets, Q1 FY2025, at 2025-03-31$68.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-13, accession 0000950170-25-069827.Report this figure62.5Current assets, Q2 FY2025, at 2025-06-30$62.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-12, accession 0000950170-25-106947.Report this figure55.7Current assets, Q3 FY2025, at 2025-09-30$55.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-12, accession 0001193125-25-276160.Report this figure45.6Current assets, FY2025, at 2025-12-31$45.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-07, accession 0001193125-26-339257.Report this figure36.7Current assets, Q1 FY2026, at 2026-03-31$36.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-08, accession 0001193125-26-213423.Report this figure31.0Current assets, Q2 FY2026, at 2026-06-30$31.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-07, accession 0001193125-26-339257.Report this figure
Total assets$m102Total assets, Q3 FY2023, at 2023-09-30$101.7m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-13, accession 0001437749-23-031424.Report this figure96.3Total assets, FY2023, at 2023-12-31$96.3m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-25, accession 0000950170-25-044099.Report this figure91.1Total assets, Q1 FY2024, at 2024-03-31$91.1m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-13, accession 0000950170-24-058244.Report this figure85.9Total assets, Q2 FY2024, at 2024-06-30$85.9m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-12, accession 0000950170-24-095102.Report this figure79.5Total assets, Q3 FY2024, at 2024-09-30$79.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-12, accession 0000950170-24-124668.Report this figure76.4Total assets, FY2024, at 2024-12-31$76.4m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-25, accession 0001193125-26-124396.Report this figure70.7Total assets, Q1 FY2025, at 2025-03-31$70.7m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-13, accession 0000950170-25-069827.Report this figure64.5Total assets, Q2 FY2025, at 2025-06-30$64.5m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-12, accession 0000950170-25-106947.Report this figure58.0Total assets, Q3 FY2025, at 2025-09-30$58.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-12, accession 0001193125-25-276160.Report this figure47.6Total assets, FY2025, at 2025-12-31$47.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-07, accession 0001193125-26-339257.Report this figure37.9Total assets, Q1 FY2026, at 2026-03-31$37.9m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-08, accession 0001193125-26-213423.Report this figure32.3Total assets, Q2 FY2026, at 2026-06-30$32.3m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-07, accession 0001193125-26-339257.Report this figure
Current liabilities$m3.4Current liabilities, Q3 FY2023, at 2023-09-30$3.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-13, accession 0001437749-23-031424.Report this figure5.2Current liabilities, FY2023, at 2023-12-31$5.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-25, accession 0000950170-25-044099.Report this figure5.3Current liabilities, Q1 FY2024, at 2024-03-31$5.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-13, accession 0000950170-24-058244.Report this figure5.7Current liabilities, Q2 FY2024, at 2024-06-30$5.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-12, accession 0000950170-24-095102.Report this figure5.8Current liabilities, Q3 FY2024, at 2024-09-30$5.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-12, accession 0000950170-24-124668.Report this figure5.0Current liabilities, FY2024, at 2024-12-31$5.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-25, accession 0001193125-26-124396.Report this figure5.4Current liabilities, Q1 FY2025, at 2025-03-31$5.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-13, accession 0000950170-25-069827.Report this figure6.8Current liabilities, Q2 FY2025, at 2025-06-30$6.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-12, accession 0000950170-25-106947.Report this figure8.2Current liabilities, Q3 FY2025, at 2025-09-30$8.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-12, accession 0001193125-25-276160.Report this figure8.3Current liabilities, FY2025, at 2025-12-31$8.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-07, accession 0001193125-26-339257.Report this figure7.5Current liabilities, Q1 FY2026, at 2026-03-31$7.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-08, accession 0001193125-26-213423.Report this figure5.5Current liabilities, Q2 FY2026, at 2026-06-30$5.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-07, accession 0001193125-26-339257.Report this figure
Total liabilities$m3.4Total liabilities, Q3 FY2023, at 2023-09-30$3.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-13, accession 0001437749-23-031424.Report this figure5.2Total liabilities, FY2023, at 2023-12-31$5.2m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-25, accession 0000950170-25-044099.Report this figure5.3Total liabilities, Q1 FY2024, at 2024-03-31$5.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-13, accession 0000950170-24-058244.Report this figure5.7Total liabilities, Q2 FY2024, at 2024-06-30$5.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-12, accession 0000950170-24-095102.Report this figure5.8Total liabilities, Q3 FY2024, at 2024-09-30$5.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-12, accession 0000950170-24-124668.Report this figure5.0Total liabilities, FY2024, at 2024-12-31$5.0m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-25, accession 0001193125-26-124396.Report this figure5.4Total liabilities, Q1 FY2025, at 2025-03-31$5.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-13, accession 0000950170-25-069827.Report this figure6.8Total liabilities, Q2 FY2025, at 2025-06-30$6.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-12, accession 0000950170-25-106947.Report this figure8.2Total liabilities, Q3 FY2025, at 2025-09-30$8.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-12, accession 0001193125-25-276160.Report this figure8.3Total liabilities, FY2025, at 2025-12-31$8.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-07, accession 0001193125-26-339257.Report this figure7.5Total liabilities, Q1 FY2026, at 2026-03-31$7.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-08, accession 0001193125-26-213423.Report this figure5.5Total liabilities, Q2 FY2026, at 2026-06-30$5.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-07, accession 0001193125-26-339257.Report this figure
Shareholders' equity$m98.3Shareholders' equity, Q3 FY2023, at 2023-09-30$98.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-12, accession 0000950170-24-124668.Report this figure91.0Shareholders' equity, FY2023, at 2023-12-31$91.0m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-25, accession 0001193125-26-124396.Report this figure85.8Shareholders' equity, Q1 FY2024, at 2024-03-31$85.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001193125-25-276160.Report this figure80.2Shareholders' equity, Q2 FY2024, at 2024-06-30$80.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001193125-25-276160.Report this figure73.7Shareholders' equity, Q3 FY2024, at 2024-09-30$73.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001193125-25-276160.Report this figure71.5Shareholders' equity, FY2024, at 2024-12-31$71.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-07, accession 0001193125-26-339257.Report this figure65.3Shareholders' equity, Q1 FY2025, at 2025-03-31$65.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-07, accession 0001193125-26-339257.Report this figure57.7Shareholders' equity, Q2 FY2025, at 2025-06-30$57.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-07, accession 0001193125-26-339257.Report this figure49.8Shareholders' equity, Q3 FY2025, at 2025-09-30$49.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001193125-25-276160.Report this figure39.4Shareholders' equity, FY2025, at 2025-12-31$39.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-07, accession 0001193125-26-339257.Report this figure30.5Shareholders' equity, Q1 FY2026, at 2026-03-31$30.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-07, accession 0001193125-26-339257.Report this figure26.8Shareholders' equity, Q2 FY2026, at 2026-06-30$26.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-07, accession 0001193125-26-339257.Report this figure

Cash flow

Operating cash flow−$9.6m, Q2 FY2026
Capital expenditure$0, Q2 FY2026
Share repurchases$0, Q4 FY2023
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(3.9)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$3.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-12, accession 0000950170-24-124668. Derived: 9-month figure less the 6-month figure.Report this figure(5.6)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$5.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-25, accession 0000950170-25-044099. Derived: 12-month figure less the 9-month figure.Report this figure(4.7)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$4.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-13, accession 0000950170-25-069827.Report this figure(4.5)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$4.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-12, accession 0000950170-25-106947. Derived: 6-month figure less the 3-month figure.Report this figure(4.8)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$4.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001193125-25-276160. Derived: 9-month figure less the 6-month figure.Report this figure(7.1)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$7.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-25, accession 0001193125-26-124396. Derived: 12-month figure less the 9-month figure.Report this figure(6.0)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$6.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-08, accession 0001193125-26-213423.Report this figure(7.3)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$7.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-07, accession 0001193125-26-339257. Derived: 6-month figure less the 3-month figure.Report this figure(6.0)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$6.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001193125-25-276160. Derived: 9-month figure less the 6-month figure.Report this figure(10.5)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$10.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-25, accession 0001193125-26-124396. Derived: 12-month figure less the 9-month figure.Report this figure(9.6)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$9.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-08, accession 0001193125-26-213423.Report this figure(9.6)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$9.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-07, accession 0001193125-26-339257. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.0Capital expenditure, Q3 FY2023, three months to 2023-09-30$1.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-12, accession 0000950170-24-124668. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-25, accession 0000950170-25-044099. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2024, three months to 2024-03-31$6.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-13, accession 0000950170-25-069827.Report this figure0.0Capital expenditure, Q2 FY2024, three months to 2024-06-30$3.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-12, accession 0000950170-25-106947. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2024, three months to 2024-09-30$10.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-12, accession 0001193125-25-276160. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-25, accession 0001193125-26-124396. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$9.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-08, accession 0001193125-26-213423.Report this figure0.0Capital expenditure, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-07, accession 0001193125-26-339257. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2025, three months to 2025-09-30$7.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-12, accession 0001193125-25-276160. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2025, three months to 2025-12-31$7.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-25, accession 0001193125-26-124396. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-08, accession 0001193125-26-213423.Report this figure0.0Capital expenditure, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-07, accession 0001193125-26-339257. Derived: 6-month figure less the 3-month figure.Report this figure
Share repurchases$mnot reported0.0Share repurchases, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2025-03-25, accession 0000950170-25-044099. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported

Shares

Diluted shares (weighted)8.91m, Q2 FY2026
Line itemUnitQ1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares127Diluted shares (weighted), Q1 FY2023, three months to 2023-03-31126,624,110 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-13, accession 0000950170-24-058244.Report this figure127Diluted shares (weighted), Q2 FY2023, three months to 2023-06-30126,622,798 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-12, accession 0000950170-24-095102.Report this figure126Diluted shares (weighted), Q3 FY2023, three months to 2023-09-30125,793,112 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-12, accession 0000950170-24-124668.Report this figure125Diluted shares (weighted), Q1 FY2024, three months to 2024-03-31125,319,778 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-13, accession 0000950170-25-069827.Report this figure126Diluted shares (weighted), Q2 FY2024, three months to 2024-06-30125,732,140 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-12, accession 0000950170-25-106947.Report this figure126Diluted shares (weighted), Q3 FY2024, three months to 2024-09-30125,772,664 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001193125-25-276160.Report this figure8.6Diluted shares (weighted), Q1 FY2025, three months to 2025-03-318,622,289 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-08, accession 0001193125-26-213423.Report this figure8.6Diluted shares (weighted), Q2 FY2025, three months to 2025-06-308,622,289 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-07, accession 0001193125-26-339257.Report this figure129Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30129,171,424 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001193125-25-276160.Report this figure8.6Diluted shares (weighted), Q1 FY2026, three months to 2026-03-318,622,289 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-08, accession 0001193125-26-213423.Report this figure8.9Diluted shares (weighted), Q2 FY2026, three months to 2026-06-308,908,511 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-07, accession 0001193125-26-339257.Report this figure

Shares outstanding: 9.98mShares outstanding, period not labelled, at 2026-07-319,979,298 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-07, accession 0001193125-26-339257.Report this figure at Jul 31, 2026, from the cover of the 10-Q filed Aug 7, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:41 ET. Listed shows no prices and gives no investment advice.